The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g 2 Regulatory News (MIG)

Share Price Information for Mobeus I&g 2 (MIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.50
Bid: 59.00
Ask: 62.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.085%)
Open: 62.00
High: 62.00
Low: 60.50
Prev. Close: 60.50
MIG Live PriceLast checked at -
Mobeus Income & Growth 2 VCT is an Investment Trust

To provide investors with a regular income stream, arising both from the income generated by companies selected for the portfolio and from realising any growth in capital, while continuing at all times to qualify as a VCT.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Offers for Subscription and Issue of Prospectus

5 Oct 2022 13:50

RNS Number : 9183B
Mobeus Income & Growth 2 VCT PLC
05 October 2022
 

Mobeus Income & Growth VCT plc (LEI: 213800HKOSEVWS7YPH79)

Mobeus Income & Growth 2 VCT plc (LEI: 213800LY62XLI1B4VX35)

Mobeus Income & Growth 4 VCT plc (LEI: 213800IFNJ65R8AQW943)

The Income & Growth VCT plc (LEI: 213800FPC15FNM74YD92)

 

Offers for Subscription and Issue of Prospectus

This announcement is made jointly by Mobeus Income & Growth VCT plc (MIG), Mobeus Income & Growth 2 VCT plc (MIG 2), Mobeus Income & Growth 4 VCT plc (MIG 4) and The Income & Growth VCT plc (I&G) (together the Companies and each a Company), which are advised by Gresham House Asset Management Limited (Gresham House).

The boards of the Companies are pleased to announce the launch of offers for subscription to raise, in aggregate, up to £47 million, with over-allotment facilities to raise, in aggregate, up to a further £29 million (together the Offers and each an Offer). The amount each Company is seeking to raise is set out below:

 

MIG

MIG 2

MIG 4

I&G

Maximum amount to be raised (excluding the over-allotment facility)

£14 million

£8 million

£11 million

£14 million

Maximum amount to be raised (including the over-allotment facility)

£22 million

£16 million

£16 million

£22 million

Full details of the Offers are contained in the prospectus issued by the Companies today (Prospectus). The Offers will open for applications at 9.00 a.m. on 17 October 2022 and will close for Applications (unless fully subscribed earlier or otherwise at the discretion of the relevant Board) at 5.30 p.m. on 27 March 2023. If a board decides (in consultation with Gresham House) to utilise its Company's over-allotment facility, this will be advised through a RIS announcement.

Investors can select which of the Companies they wish to invest in. Investors can apply to invest equally in all of the Companies or different amounts in one or more of the Companies (subject to an Offer not having closed prior to the application form being processed). The amount subscribed under each Offer will be invested into new ordinary shares of 1p each in the relevant Company.

Applications under an Offer will be accepted on a 'first-come, first-served' basis, subject always to the discretion of the relevant Company's board of directors. For these purposes 'first-come, first-served' shall be assessed based on the date and time of receipt of a fully completed application, subject to receipt of application monies (in full) in cleared funds within five business days thereafter to retain the applicant's position of priority.

The Prospectus, which has been approved by the Financial Conduct Authority, will shortly be available for download from the Companies' websites at:

· MIG: www.migvct.co.uk

· MIG 2: www.mig2vct.co.uk

· MIG 4: www.mig4vct.co.uk

· I&G: www.theincomeandgrowthvct.co.uk

The Prospectus will also shortly be available for inspection at the National Storage Mechanism, which is located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

Pursuant to an offers' agreement dated 5 October 2022 relating to the Offers between, among others, each Company and Gresham House, each Company will pay Gresham House a fee of an amount representing 3.0% of the Investment Amounts (as defined in the Prospectus) in respect of applications accepted under its Offer, less an amount equal to (i) 0.5% of the Investment Amounts in respect of investors who receive advice from a financial adviser other than in respect of a Professional Client (as defined in the Prospectus) investor (and the application forms are completed by the financial adviser on this basis), (ii) 0.5% of the Investment Amounts where initial commission is waived by intermediaries in respect of applications from 'execution only' investors and Professional Client investors, (iii) 0.5% of the Investment Amounts in respect of direct investors who are existing shareholders in one or more of the Companies and (iv) any further amounts by which Gresham House agrees (at its discretion, but subject to not reducing Offer Costs (as defined in the Prospectus) to nil) to reduce its fees in respect of such applications, such amount being inclusive of VAT.

 

As Gresham House is a related party of each Company under the Listing Rules of the Financial Conduct Authority, the payment of such fee by each Company to Gresham House is a transaction to which Listing Rule 11.1.10 applies.

 

For further information, please contact:

Gresham House Asset Management Limited

Company Secretary

Telephone: +44 (0)20 7382 0999

 

 

 

Please note that the Mobeus VCTs and Gresham House cannot give any financial, legal, tax or investment advice.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIFLFSFIILEIIF
Date   Source Headline
2nd Mar 20219:00 amRNSInterim Management Statement to 31 December 2020
25th Feb 20219:30 amRNSInvestee Company - Intention to Float
26th Jan 20213:00 pmRNSReplacement - Transaction in Own Shares
11th Jan 202112:00 pmRNSRealisation of Investment
17th Dec 202011:40 amRNSTransaction in Own Shares and Total Voting Rights
2nd Dec 20203:23 pmRNSInterim Report
29th Sep 20207:00 amRNSTransaction in Own Shares
9th Sep 20203:58 pmRNSIMPACT OF RECENT DISPOSALS UPON NET ASSET VALUE
9th Sep 202011:05 amRNSAGM Results
8th Sep 20203:30 pmRNSInterim Management Statement to 30 June 2020
7th Sep 20207:00 amRNSRealisation of Investment
17th Aug 20207:30 amRNSRealisation of Investment
10th Aug 20208:54 amRNSRevised AGM Arrangements
3rd Jul 20204:00 pmRNSTransaction in Own Shares and Total Voting Rights
1st Jul 20207:00 amRNSAnnual Financial Report
14th May 20209:15 amRNSDividend Declaration
2nd Apr 20205:10 pmRNSIssue of Equity
30th Mar 202012:40 pmRNSPublication of Suppl.Prospcts
27th Mar 20207:00 amRNSNet Asset Value(s)
23rd Mar 202011:30 amRNSTransaction in Own Shares
2nd Mar 202010:23 amRNSInterim Management Statement to 31 December 2019
28th Feb 20201:09 pmRNSFundraising Update
26th Feb 20202:48 pmRNSInterim Dividend
25th Feb 20203:15 pmRNSPublication of Suppl.Prospcts
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
14th Feb 20207:00 amRNSRealisation of Three Investments
7th Feb 20206:40 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:37 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:36 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:34 pmRNSPublication of Suppl.Prospcts
7th Feb 20206:30 pmRNSPublication of Suppl.Prospcts
6th Feb 20203:45 pmRNSOffer Increase
3rd Feb 202011:30 amRNSTotal Voting Rights
13th Jan 202011:00 amRNSFundraising Update
8th Jan 20204:20 pmRNSIssue of Equity & Total Voting Rights
20th Dec 20193:00 pmRNSFundraising Update
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
20th Dec 20192:15 pmRNSPublication of Suppl.Prospcts
12th Dec 201912:40 pmRNSTransaction in Own Shares
28th Nov 201910:15 amRNSHalf-Year Report for the six months ended 30/09/19
20th Nov 20191:00 pmRNSHalf-year Report
5th Nov 20194:00 pmRNSReduction of Capital
25th Oct 20194:00 pmRNSPublication of a Prospectus
11th Oct 20193:00 pmRNSResult of Meeting
1st Oct 201910:00 amRNSTotal Voting Rights
27th Sep 201912:00 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.